-
1
-
-
52949105139
-
Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies
-
Markman M. Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies. Trends Pharmacol Sci. 2008;29:515-9.
-
(2008)
Trends Pharmacol Sci.
, vol.29
, pp. 515-519
-
-
Markman, M.1
-
2
-
-
34848917530
-
Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy
-
Colombo N, Gore M. Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy. Crit Rev Oncol Hematol. 2007;64:129-38.
-
(2007)
Crit Rev Oncol Hematol.
, vol.64
, pp. 129-138
-
-
Colombo, N.1
Gore, M.2
-
3
-
-
84872114095
-
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
-
Marchini S, Fruscio R, Clivio L, Beltrame L, Porcu L, Fuso NI, et al. Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Eur J Cancer. 2013;49:520-30.
-
(2013)
Eur J Cancer.
, vol.49
, pp. 520-530
-
-
Marchini, S.1
Fruscio, R.2
Clivio, L.3
Beltrame, L.4
Porcu, L.5
Fuso, N.I.6
-
4
-
-
77950188189
-
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture
-
Helleman J, Smid M, Jansen MP, van der Burg ME, Berns EM. Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture. Gynecol Oncol. 2010;117:170-6.
-
(2010)
Gynecol Oncol.
, vol.117
, pp. 170-176
-
-
Helleman, J.1
Smid, M.2
Jansen, M.P.3
Burg, M.E.4
Berns, E.M.5
-
5
-
-
84879106039
-
Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
-
Gupta N, Xu Z, El-Sehemy A, Steed H, Fu Y. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells. Gynecol Oncol. 2013;130:200-6.
-
(2013)
Gynecol Oncol.
, vol.130
, pp. 200-206
-
-
Gupta, N.1
Xu, Z.2
El-Sehemy, A.3
Steed, H.4
Fu, Y.5
-
6
-
-
84857411051
-
Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
-
Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One. 2012;7:e30563.
-
(2012)
PLoS One.
, vol.7
, pp. e30563
-
-
Kidd, S.1
Spaeth, E.2
Watson, K.3
Burks, J.4
Lu, H.5
Klopp, A.6
-
7
-
-
79961006281
-
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
-
McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest. 2011;121:3206-19.
-
(2011)
J Clin Invest.
, vol.121
, pp. 3206-3219
-
-
McLean, K.1
Gong, Y.2
Choi, Y.3
Deng, N.4
Yang, K.5
Bai, S.6
-
8
-
-
84861589643
-
Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties
-
Lis R, Touboul C, Raynaud CM, Malek JA, Suhre K, Mirshahi M, et al. Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties. PLoS One. 2012;7:e38340.
-
(2012)
PLoS One.
, vol.7
, pp. e38340
-
-
Lis, R.1
Touboul, C.2
Raynaud, C.M.3
Malek, J.A.4
Suhre, K.5
Mirshahi, M.6
-
9
-
-
80052592013
-
Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids
-
Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM, et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell. 2011;20:370-83.
-
(2011)
Cancer Cell.
, vol.20
, pp. 370-383
-
-
Roodhart, J.M.1
Daenen, L.G.2
Stigter, E.C.3
Prins, H.J.4
Gerrits, J.5
Houthuijzen, J.M.6
-
10
-
-
77951118936
-
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
-
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071-6.
-
(2010)
Nature.
, vol.464
, pp. 1071-1076
-
-
Gupta, R.A.1
Shah, N.2
Wang, K.C.3
Kim, J.4
Horlings, H.M.5
Wong, D.J.6
-
11
-
-
84890478464
-
Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines
-
Padua AC, Fonseca AS, Muys BR, de Barros E, Lima Bueno R, Burger MC, et al. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells. 2013;31:2827-32.
-
(2013)
Stem Cells.
, vol.31
, pp. 2827-2832
-
-
Padua, A.C.1
Fonseca, A.S.2
Muys, B.R.3
Barros, E.4
Lima Bueno, R.5
Burger, M.C.6
Souza, J.E.7
-
12
-
-
80053045739
-
Molecular mechanisms of long noncoding RNAs
-
Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904-14.
-
(2011)
Mol Cell.
, vol.43
, pp. 904-914
-
-
Wang, K.C.1
Chang, H.Y.2
-
13
-
-
84879833696
-
Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer
-
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013;9:587-97.
-
(2013)
Int J Biol Sci.
, vol.9
, pp. 587-597
-
-
Xu, Z.Y.1
Yu, Q.M.2
Du, Y.A.3
Yang, L.T.4
Dong, R.Z.5
Huang, L.6
-
14
-
-
78651390167
-
Long intergenic noncoding RNAs: new links in cancer progression
-
Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71:3-7.
-
(2011)
Cancer Res.
, vol.71
, pp. 3-7
-
-
Tsai, M.C.1
Spitale, R.C.2
Chang, H.Y.3
-
15
-
-
33646070846
-
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
-
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125:315-26.
-
(2006)
Cell.
, vol.125
, pp. 315-326
-
-
Bernstein, B.E.1
Mikkelsen, T.S.2
Xie, X.3
Kamal, M.4
Huebert, D.J.5
Cuff, J.6
-
16
-
-
33646865180
-
Control of developmental regulators by Polycomb in human embryonic stem cells
-
Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125:301-13.
-
(2006)
Cell.
, vol.125
, pp. 301-313
-
-
Lee, T.I.1
Jenner, R.G.2
Boyer, L.A.3
Guenther, M.G.4
Levine, S.S.5
Kumar, R.M.6
-
17
-
-
33846569960
-
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
-
Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. 2007;39:237-42.
-
(2007)
Nat Genet.
, vol.39
, pp. 237-242
-
-
Ohm, J.E.1
McGarvey, K.M.2
Yu, X.3
Cheng, L.4
Schuebel, K.E.5
Cope, L.6
-
18
-
-
33846649587
-
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
-
Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007;39:232-6.
-
(2007)
Nat Genet.
, vol.39
, pp. 232-236
-
-
Schlesinger, Y.1
Straussman, R.2
Keshet, I.3
Farkash, S.4
Hecht, M.5
Zimmerman, J.6
-
19
-
-
77950650405
-
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
-
Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010;20:440-6.
-
(2010)
Genome Res.
, vol.20
, pp. 440-446
-
-
Teschendorff, A.E.1
Menon, U.2
Gentry-Maharaj, A.3
Ramus, S.J.4
Weisenberger, D.J.5
Shen, H.6
-
20
-
-
33846576622
-
Epigenetic stem cell signature in cancer
-
Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, et al. Epigenetic stem cell signature in cancer. Nat Genet. 2007;39:157-8.
-
(2007)
Nat Genet.
, vol.39
, pp. 157-158
-
-
Widschwendter, M.1
Fiegl, H.2
Egle, D.3
Mueller-Holzner, E.4
Spizzo, G.5
Marth, C.6
-
21
-
-
84903124951
-
Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer
-
Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, et al. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol. 2014;134:121-8.
-
(2014)
Gynecol Oncol.
, vol.134
, pp. 121-128
-
-
Qiu, J.J.1
Lin, Y.Y.2
Ye, L.C.3
Ding, J.X.4
Feng, W.W.5
Jin, H.Y.6
-
22
-
-
84907834115
-
Prognostic value of long non-coding RNA HOTAIR in various cancers
-
Deng Q, Sun H, He B, Pan Y, Gao T, Chen J, et al. Prognostic value of long non-coding RNA HOTAIR in various cancers. PLoS One. 2014;9:e110059.
-
(2014)
PLoS One.
, vol.9
, pp. e110059
-
-
Deng, Q.1
Sun, H.2
He, B.3
Pan, Y.4
Gao, T.5
Chen, J.6
-
23
-
-
61449106520
-
Survival-related profile, pathways, and transcription factors in ovarian cancer
-
Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, et al. Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med. 2009;6:e24.
-
(2009)
PLoS Med.
, vol.6
, pp. e24
-
-
Crijns, A.P.1
Fehrmann, R.S.2
Jong, S.3
Gerbens, F.4
Meersma, G.J.5
Klip, H.G.6
-
24
-
-
79959838081
-
Integrated genomic analyses of ovarian carcinoma
-
Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609-15.
-
(2011)
Nature.
, vol.474
, pp. 609-615
-
-
Bell, D.1
Berchuck, A.2
Birrer, M.3
Chien, J.4
Cramer, D.W.5
Dao, F.6
-
25
-
-
0034679027
-
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer
-
Widschwendter M, Berger J, Hermann M, Muller HM, Amberger A, Zeschnigk M, et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst. 2000;92:826-32.
-
(2000)
J Natl Cancer Inst.
, vol.92
, pp. 826-832
-
-
Widschwendter, M.1
Berger, J.2
Hermann, M.3
Muller, H.M.4
Amberger, A.5
Zeschnigk, M.6
-
26
-
-
0346121833
-
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
-
Muller HM, Fiegl H, Goebel G, Hubalek MM, Widschwendter A, Muller-Holzner E, et al. MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br J Cancer. 2003;89:1934-9.
-
(2003)
Br J Cancer.
, vol.89
, pp. 1934-1939
-
-
Muller, H.M.1
Fiegl, H.2
Goebel, G.3
Hubalek, M.M.4
Widschwendter, A.5
Muller-Holzner, E.6
-
27
-
-
77949533111
-
An epigenetic signature in peripheral blood predicts active ovarian cancer
-
Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009;4:e8274.
-
(2009)
PLoS One.
, vol.4
, pp. e8274
-
-
Teschendorff, A.E.1
Menon, U.2
Gentry-Maharaj, A.3
Ramus, S.J.4
Gayther, S.A.5
Apostolidou, S.6
-
28
-
-
79957851822
-
Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies
-
Teschendorff AE, Zhuang J, Widschwendter M. Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies. Bioinformatics. 2011;27:1496-505.
-
(2011)
Bioinformatics.
, vol.27
, pp. 1496-1505
-
-
Teschendorff, A.E.1
Zhuang, J.2
Widschwendter, M.3
-
29
-
-
84873394089
-
Pluripotent stem cells escape from senescence-associated DNA methylation changes
-
Koch CM, Reck K, Shao K, Lin Q, Joussen S, Ziegler P, et al. Pluripotent stem cells escape from senescence-associated DNA methylation changes. Genome Res. 2013;23:248-59.
-
(2013)
Genome Res.
, vol.23
, pp. 248-259
-
-
Koch, C.M.1
Reck, K.2
Shao, K.3
Lin, Q.4
Joussen, S.5
Ziegler, P.6
-
30
-
-
0033550589
-
ICON2 trial. UK consensus statement on standard practice for chemotherapy in ovarian cancer
-
Gore ME. ICON2 trial. UK consensus statement on standard practice for chemotherapy in ovarian cancer. Lancet. 1999;353:587-8.
-
(1999)
Lancet
, vol.353
, pp. 587-588
-
-
Gore, M.E.1
-
31
-
-
0032517581
-
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study
-
ICON2 Consortium. ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study. Lancet. 1998;352:1571-6.
-
(1998)
Lancet
, vol.352
, pp. 1571-1576
-
-
-
32
-
-
34347379142
-
Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis
-
Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;99:847-57.
-
(2007)
J Natl Cancer Inst.
, vol.99
, pp. 847-857
-
-
Ardizzoni, A.1
Boni, L.2
Tiseo, M.3
Fossella, F.V.4
Schiller, J.H.5
Paesmans, M.6
-
33
-
-
77249130793
-
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
-
Burger H, Zoumaro-Djayoon A, Boersma AW, Helleman J, Berns EM, Mathijssen RH, et al. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2). Br J Pharmacol. 2010;159:898-908.
-
(2010)
Br J Pharmacol.
, vol.159
, pp. 898-908
-
-
Burger, H.1
Zoumaro-Djayoon, A.2
Boersma, A.W.3
Helleman, J.4
Berns, E.M.5
Mathijssen, R.H.6
-
34
-
-
84929948066
-
HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer
-
Jing L, Yuan W, Ruofan D, Jinjin Y, Haifeng Q. HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumour Biol. 2014;36:3611-9.
-
(2014)
Tumour Biol
, vol.36
, pp. 3611-3619
-
-
Jing, L.1
Yuan, W.2
Ruofan, D.3
Jinjin, Y.4
Haifeng, Q.5
-
35
-
-
0022482045
-
A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)
-
Arseneau J, Blessing JA, Stehman FB, McGehee R. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Invest New Drugs. 1986;4:187-91.
-
(1986)
Invest New Drugs.
, vol.4
, pp. 187-191
-
-
Arseneau, J.1
Blessing, J.A.2
Stehman, F.B.3
McGehee, R.4
-
36
-
-
0025635642
-
A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study
-
Weiss GR, Green S, Hannigan EV, Boutselis JG, Surwit EA, Wallace DL, et al. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. Gynecol Oncol. 1990;39:332-6.
-
(1990)
Gynecol Oncol.
, vol.39
, pp. 332-336
-
-
Weiss, G.R.1
Green, S.2
Hannigan, E.V.3
Boutselis, J.G.4
Surwit, E.A.5
Wallace, D.L.6
-
37
-
-
0024747607
-
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study
-
McGuire III WP, Arseneau J, Blessing JA, DiSaia PJ, Hatch KD, Given Jr FT, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1989;7:1462-8.
-
(1989)
J Clin Oncol.
, vol.7
, pp. 1462-1468
-
-
McGuire, W.P.1
Arseneau, J.2
Blessing, J.A.3
DiSaia, P.J.4
Hatch, K.D.5
Given, F.T.6
-
38
-
-
84927913633
-
The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian Cancer cells through the regulation of cell cycle arrest and apoptosis
-
Qiu JJ, Wang Y, Ding JX, Jin HY, Yang G, Hua KQ. The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian Cancer cells through the regulation of cell cycle arrest and apoptosis. Exp Cell Res. 2015;333:238-48.
-
(2015)
Exp Cell Res.
, vol.333
, pp. 238-248
-
-
Qiu, J.J.1
Wang, Y.2
Ding, J.X.3
Jin, H.Y.4
Yang, G.5
Hua, K.Q.6
|